Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
Pietro Sollena, Vasiliki Nikolaou, Nikolaos Soupos, Ηλίας Κοττέας, Dimitra Voudouri, Alexandros Stratigos, Davide Fattore, Maria Carmela Annunziata, Armando Orlandi, Lucia Di Nardo, Zoé Apalla, F. Deilhes, Maria Concetta Romano, Gabriella Fabbrocini, V. Sibaud, Ketty Peris, the European Network for Cutaneous ADverse event of Oncologic drugs (ENCADO) group
Topics & Concepts
MedicineVitiligoBreast cancerAdverse effectDermatologyInternal medicineCancerQuality of life (healthcare)Dermatology Life Quality IndexOncologyDiseaseNursingAdvanced Breast Cancer TherapiesMelanoma and MAPK PathwaysColorectal Cancer Treatments and Studies